Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Characterisation of ER-beta functions in prostate cancer (ChIP-Seq)

ABSTRACT: Characterisation of ER-beta functions in prostate cancer (ChIP-Seq)

PROVIDER: PRJNA1061541 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR27443100.fastq.gz	Fastqsanger.gz
	SRR27443100_1.fastq.gz	Fastqsanger.gz
	SRR27443100_2.fastq.gz	Fastqsanger.gz
	SRR27443101.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 124

Similar Datasets

Characterisation of ER-beta functions in prostate cancer

Project description:Characterisation of ER-beta functions in prostate cancer

| PRJNA1061241 | ENA

Characterisation of ER-beta functions in prostate cancer (RNA-Seq)

Project description:Characterisation of ER-beta functions in prostate cancer (RNA-Seq)

| PRJNA1061248 | ENA

Characterisation of ER-beta functions in prostate cancer (ATAC-Seq)

Project description:Characterisation of ER-beta functions in prostate cancer (ATAC-Seq)

| PRJNA1061247 | ENA

Characterisation of ER-beta functions in prostate cancer (ATAC-Seq)

Project description:To investigate the effect of a novel ER-beta selective ligand alone and with Enzalutamide on chromatin accessabilty in prostate cell lines

2024-01-31 | GSE252577 | GEO

Characterisation of ER-beta functions in prostate cancer (RNA-Seq)

Project description:To investigate the effect of a novel ER-beta selective ligand alone and with Enzalutamide on RNA expression in prostate cancer cell lines

2024-01-31 | GSE252576 | GEO

Characterisation of ER-beta functions in prostate cancer (ChIP-Seq)

Project description:To investigate the effect of a novel ER-beta selective ligand alone and with Enzalutamide on AR, ARv7, MYC genomic binding and H3K27ac distribution in prostate cancer cell lines

2024-01-31 | GSE252635 | GEO

Characterisation of ER-beta functions in prostate cancer

Project description:This SuperSeries is composed of the SubSeries listed below.

2024-01-31 | GSE252578 | GEO

Identification of the ER-beta cistrome in ER-beta expressing MDA-MB-231 cells [ChIP-seq]

Project description:We have utilized ChIPseq to identify the ER-beta cistrome in ER-beta expressing MDA-MB-231 triple negative breast cancer cells. ER-beta has been identified as a tumor suppressor in breast cancer and recent reports have demonstrated that ER-beta protein is detectable at moderate to high levels in approximately 30% of triple negative breast tumors. Increased expression of ER-beta in triple negative breast cancer has also been reported to be associated with improved recurrence-free survival. Treatment of ER-beta expressing triple negative breast cancer cells with estrogen, or the ER-beta selective agonist, LY500307, results in decreased cell proliferation, invasion and migration. To begin to identify the molecular mechanisms by which ER-beta elicits tumor suppressive effects in triple negative breast cancer, we performed ChIPseq studies and identified the genome-wide binding sites for ER-beta following exposure to 1nM estrogen or 10nM LY500307 for 3 hours. Over 28,000 and 10,000 unique ER-beta binding sites were identifed in response to these two ligands respectively. The top transcription factor motifs identified under both treatment conditions were estrogen response elements and AP1 response elements. The majority of ER-beta binding sites were found at enhancer regions located within introns or intergenic chromatin regions followed by gene promoters.

2018-08-23 | GSE108979 | GEO

Genome wide analysis of ER beta in U2OS cells

Project description:This SuperSeries is composed of the following subset Series: GSE21769: Genome wide expression analysis of ER alpha and beta with or without E2 treatment in U2OS cell line. GSE21770: Genome-wide maps of ER beta binding sites in U2OS cells Refer to individual Series

2010-05-11 | E-GEOD-21790 | biostudies-arrayexpress

Identification of the ER-beta cistrome in ER-beta expressing MDA-MB-231 cells [ChIP-seq]

Project description:Identification of the ER-beta cistrome in ER-beta expressing MDA-MB-231 cells [ChIP-seq]

| PRJNA429300 | ENA